Ianalumab plus Eltrombopag in Immune Thrombocytopenia

Ianalumab plus eltrombopag led to a longer time to treatment failure than placebo plus eltrombopag. (Funded by Novartis; VAYHIT2 ClinicalTrials.gov number, NCT05653219.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-12-09
DOI
https://doi.org/10.1056/nejmoa2515168
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ianalumab plus Eltrombopag in Immune Thrombocytopenia

Nichola Cooper, Thomas Stauch, Patrick Urban, Tatsunori Goto et al.
New England Journal of Medicine
Platelet Disorders and Treatments
article

Ianalumab plus Eltrombopag in Immune Thrombocytopenia

Nichola Cooper, Thomas Stauch, Patrick Urban, Tatsunori Goto, Masaki Iino, Azizan Sharif, Theera Ruchutrakool, Judith Fronczek, Waleed Ghanima, Elena Rossi, Marc Michel, Libor Červínek, Uttam Kumar Nath, Roger E. G. Schutgens, Hanny T. Al-Samkari, Adam C. Cuker, Thomas Zander, Jae‐Ho Yoon, Lien Deleu, Ming Hou, Lei Zhang, Jing Sun, Hung Chang, Matthew Foster, Francesco Zaja, Marine Weill
article en

Abstract

Ianalumab plus eltrombopag led to a longer time to treatment failure than placebo plus eltrombopag. (Funded by Novartis; VAYHIT2 ClinicalTrials.gov number, NCT05653219.).

New England Journal of Medicine
Università Cattolica del Sacro Cuore (IT), Novartis (Switzerland) (CH), Siriraj Hospital (TH), Chang Gung University (TW), University of Oslo (NO), Utrecht University (NL), Université Paris-Est Créteil (FR), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Mahidol University (TH), Paris-Est Sup (FR), Sultanah Aminah Hospital (MY), Agostino Gemelli University Polyclinic (IT), University Medical Center Utrecht (NL), Chang Gung Memorial Hospital (TW), Massachusetts General Hospital (US), Düsseldorf University Hospital (DE), Integrated Oncology (United States) (US), University Hospital Brno (CZ), Nanfang Hospital (CN), Hôpitaux Universitaires Henri-Mondor (FR), Japanese Red Cross Nagoya Daiichi Hospital (JP), Jena University Hospital (DE), AZ Delta (BE), Institute of Hematology & Blood Diseases Hospital (CN), Centre for Inflammation Research (GB), St. Paul's Hospital (KR), University Hospital Cologne (DE), Østfold Hospital Trust (NO), The Catholic University of Korea Seoul St. Mary's Hospital (KR), Qilu Hospital of Shandong University (CN), Azienda Sanitaria Universitaria Integrata di Trieste (IT), Yamanashi Prefectural Central Hospital (JP), All India Institute of Medical Sciences Rishikesh (IN), Heinrich Heine University Düsseldorf (DE), Southern Medical University (CN), University of Pennsylvania (US)
Openalex Percentile: Top 41%
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.